Identification of small molecule sphingomyelin synthase inhibitors.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European journal of medicinal chemistry

• Publication date

  2014-02-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2013.12.002PMID 24374347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Development, Validation, and Application of a Novel Method for Mammalian Sphingomyelin Synthase Activity Measurement

  2012cited by this paper
• Impact of Sphingomyelin Synthase 1 Deficiency on Sphingolipid Metabolism and Atherosclerosis in Mice

  2012cited by this paper
• Tricyclodecan-9-yl-Xanthogenate (D609) Mechanism of Actions: A Mini-Review of Literature

  2011cited by this paper
• Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity

  2011cited by this paper
• Molecular Modeling of the Three-Dimensional Structure of Human Sphingomyelin Synthase

  2011cited by this paper
• Sphingomyelin biosynthesis: its impact on lipid metabolism and atherosclerosis

  2009cited by this paper
• Ira Tabas , Kevin Jon Williams and Jan Borén and Therapeutic Implications Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis : Update

  2007cited by this paper
• Design, synthesis, and structure-activity relationship studies of new phenolic DNA gyrase inhibitors.

  2007cited by this paper
• Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice Published, JLR Papers in Press, February 28, 2006.

  2006cited by this paper
• Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice.

  2005cited by this paper
• Identification of a family of animal sphingomyelin synthases

  2004cited by this paper
• Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells.

  2004cited by this paper
• Prodrug Modification Increases Potassium Tricyclo[5.2.1.02,6]-decan-8-yl Dithiocarbonate (D609) Chemical Stability and Cytotoxicity against U937 Leukemia Cells

  2004cited by this paper
• Mechanisms of tetrazole formation by addition of azide to nitriles.

  2002cited by this paper
• P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel

  2002cited by this paper
• Evaluation of MS-209, a novel multidrug-resistance-reversing agent, in tumour-bearing mice by technetium-99m-MIBI imaging

  2002cited by this paper
• A Catalytic Asymmetric Strecker‐Type Reaction: Interesting Reactivity Difference between TMSCN and HCN

  2000cited by this paper
• A Facile Synthesis of Substituted Phenylglycines

  2000cited by this paper
• A convenient strategy for the synthesis of 4,5-bis(o-haloaryl)isoxazoles

  2000cited by this paper

• Ceramide turnover in GtoPdb v.2025.3

  2025cites this paper
• A Review Discussing Synthesis and Translational Studies of Medicinal Agents Targeting Sphingolipid Pathways

  2025cites this paper
• Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis

  2025cites this paper
• Multiple activities of sphingomyelin synthase 2 generate saturated fatty acid– and/or monounsaturated fatty acid–containing diacylglycerol

  2024cites this paper
• A facile method for monitoring sphingomyelin synthase activity in HeLa cells using liquid chromatography/mass spectrometry.

  2024cites this paper
• Synthesis of β-Nitroamines and α-Aminonitriles by I2-Mediated Oxidative C—C Bond Formation

  2023cites this paper
• Targeting the Sphingolipid Rheostat in Gliomas

  2022cites this paper
• Drug Development in the Field of Sphinogolipid Metabolism.

  2022cites this paper
• Ceramide turnover in GtoPdb v.2021.3

  2021cites this paper
• Sphingomyelin synthase-related protein generates diacylglycerol via the hydrolysis of glycerophospholipids in the absence of ceramide

  2021cites this paper
• Ceramide turnover (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database

  2020cites this paper
• Discovery of 1,8-naphthyridin-2-one derivative as a potent and selective sphingomyelin synthase 2 inhibitor.

  2020cites this paper
• Approaches for probing and evaluating mammalian sphingolipid metabolism.

  2019cites this paper
• Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.

  2019cites this paper
• Potential therapeutic targets for atherosclerosis in sphingolipid metabolism

  2019cites this paper
• Design and Synthesis of the Diazirine-based Clickable Photo-affinity Probe Targeting Sphingomyelin Synthase 2

  2019cites this paper
• The compromise of virtual screening and its impact on drug discovery

  2019cites this paper
• Ceramide turnover (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Discovery of 4-Benzyloxybenzo[ d]isoxazole-3-amine Derivatives as Highly Selective and Orally Efficacious Human Sphingomyelin Synthase 2 Inhibitors that Reduce Chronic Inflammation in db/ db Mice.

  2018cites this paper
• Luminescence of lemon-derived carbon quantum dot and its potential application in luminescent probe for detection of Mo6+ ions.

  2018cites this paper
• Structure-inspired design of a sphingolipid mimic sphingosine-1-phosphate receptor agonist from a naturally occurring sphingomyelin synthase inhibitor.

  2018cites this paper
• Discovery and characterization of selective human sphingomyelin synthase 2 inhibitors.

  2017cites this paper
• The sphingomyelin synthase family: proteins, diseases, and inhibitors

  2017cites this paper
• Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.

  2017cites this paper
• Lipidomics in the Study of Hypertension in Metabolic Syndrome

  2017cites this paper
• Charge-Transfer-Induced Fluorescence Quenching of Anthracene Derivatives and Selective Detection of Picric Acid.

  2016cites this paper
• Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.

  2016cites this paper
• Enzymatic Targets in Atherosclerosis

  2015cites this paper
• Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors.

  2015cites this paper
• Pharmacologic Inhibition of Sphingomyelin Synthase (SMS) Activity Reduces Apolipoprotein-B Secretion from Hepatocytes and Attenuates Endotoxin-Mediated Macrophage Inflammation

  2014cites this paper
• Gold nanoparticles confined in vertically aligned silica nanochannels and their electrocatalytic activity toward ascorbic acid.

  2014cites this paper
• Analysis of Fluorescent Ceramide and Sphingomyelin Analogs: A Novel Approach for in Vivo Monitoring of Sphingomyelin Synthase Activity

  2014cites this paper